1. Weltermann A, Pabinger I, Geissler K, et al. Hypofibrinogenemia in non-M3 acute myeloid leukemia. Incidence, clinical and laboratory characteristics and prognosis. Leukemia. 1998;12:1182-1186.
2. Nur S, Anwar M, Saleem M, Ahmad PA. Disseminated intravascular coagulation in acute leukaemias at first diagnosis. Eur J Haematol. 1995;55:78-82.
3. Jagasia MH, Arrowsmith ER. Complications of Hematopoietic Neoplasms. In: Greer JP, Foerster J, LukensJN, Rodgers GM, Paraskevas F, Glader B, eds. Wintrobe's Clinical Hematology. 11th edition. Lippincott Williams & Wilkins; 2004:1921-1943.
4. Avvisati G, Lo Coco F, Diverio D, et al. AIDA (All-trans retinoic acid + Idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood. 1996;88:1390-1398.
5. Burnett AK, Grimwade D, Solomon E, Wheatley K, Goldstone AH. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the randomized MRC trial. Blood. 1999;93:4131-4143.